MAGNET Group Selects Control Medical Technology to Provide Participating Healthcare Facilities Novel Mechanical Thrombectomy Systems

    PARK CITY, UT, August 05, 2015 /24-7PressRelease/ -- Control Medical Technology is pleased to announce a three-year agreement with Mid-Atlantic Group Network of Shared Services Cooperative, also known as "MAGNET Group" one of the largest non-profit cooperative group purchasing and shared services organizations in the country.

Control Medical Technology will supply the award winning and patented Aspire Mechanical Thrombectomy Systems to MAGNET Group participating health care facilities. The ASPIRE system is a novel hand-held platform that consistently aspirates thrombus (blood clot) with improved speed, force, and control. ASPIRE systems also allow users to instantly start, stop, increase, decrease, or pulse thrombectomy force depending on what the clinician sees and feels during the procedure.

"We're excited to be able to present this leading edge technology to our participating healthcare facilities," said Steve Duke, Executive VP and COO of MAGNET Group.

Often times, basic syringe aspiration does not provide the force, speed, and volume needed to remove blood clots and/or remove larger volume of clot. Electromechanical thrombectomy systems may improve thrombectomy force and volume, but are complex, require expensive capitol equipment, and may not give the physician the ability to instantly control or feel thrombectomy force. The Aspire Mechanical Thrombectomy systems represent a bridge between manual aspiration and electromechanical devices. The aspire has high aspiration forces, requires little set up and preparation, is cost effective and it gives the physician the ability to vary aspiration force

"We are pleased to have the opportunity to work with the MAGNET Group," said Chris Livingstone, vice president of sales and marketing with Control Medical Technology. "We believe together we can provide health care providers and patients an outstanding technology at an affordable price."

Control Medical Technology's ASPIRE Thrombectomy System is now one of the largest FDA cleared platforms in the United States with four (4) over-the-wire catheters and new rapid-exchange catheters powered by a novel mechanical thrombectomy driver/pump protected by 10+ issued and pending patents. The ASPIRE platform has been successful in removing thrombus during acute myocardial infarction (AMI or heart attack), deep vein thrombosis (DVT), hemodialysis access, critical limb ischemia (CLI), and other conditions.

Control Medical Technology is headquartered in Park City, Utah. For more information about Control Medical, call 1-954-534-9345 or visit www.CONTROLMEDTECH.com.

Media Contact: Chris Livingstone
[email protected]

# # #